NCT00036361已完成3 期
Broad Effectiveness: Study With Aripiprazole
Otsuka Pharmaceutical Development & Commercialization, Inc.1 个研究点 分布在 1 个国家目标入组 444 人开始时间: 2002年7月最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 444
- 试验地点
- 1
- 主要终点
- Safety Assessments
研究概览
简要总结
The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Safety Assessments
次要结局
- Safety Assessments
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
To study therapeutic efficacy of aripiprazole augmentation in treatment resistant obsessive compulsive disorderCTRI/2021/04/032524GMC medical college
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderBipolar I DisorderNCT00046384Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderBipolar DisorderNCT00036101Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesSchizophreniaNCT00237939Otsuka Pharmaceutical Development & Commercialization, Inc.1,200
已完成
3 期
Study of Aripiprazole in Patients With Acute Bipolar ManiaBipolar DisorderNCT00097266Otsuka Pharmaceutical Development & Commercialization, Inc.615